Search

Your search keyword '"Poesen, Koen"' showing total 385 results

Search Constraints

Start Over You searched for: Author "Poesen, Koen" Remove constraint Author: "Poesen, Koen"
385 results on '"Poesen, Koen"'

Search Results

2. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

4. Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study

5. Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid-PET

7. Altered perivascular fibroblast activity precedes ALS disease onset

8. Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.

9. Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes

10. Performance of plasma pTau181 and pTau217 measured with fully automated LUMIPULSE G prototype immunoassays

17. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

18. Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.

20. Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

21. Early neurotransmitters changes in prodromal frontotemporal dementia

27. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

28. Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort

29. Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers

31. Temporal order of clinical and biomarker changes in familial frontotemporal dementia

32. Publisher Correction: Altered perivascular fibroblast activity precedes ALS disease onset

33. Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia

34. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

36. Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations

43. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

47. CSF biomarker variability in the Alzheimer's Association quality control program

48. Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties

49. CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

50. Association of Plasma p-tau181 and p-tau231 Concentrations with Cognitive Decline in Patients with Probable Dementia with Lewy Bodies

Catalog

Books, media, physical & digital resources